Vol 2005, No 66 (2005)

Table of Contents

Research & Development

Pain Therapeutics Reaps Late-stage Rewards Abstract pdf
Business Review Editor

Features

Astellas Joins Theravance in Fight against MRSA Abstract pdf
Business Review Editor
Kos Pharmaceuticals Agrees to Take on Jerini's Icatibant in North America Abstract pdf
Business Review Editor
Can European VCs and Universities Make Money from New Biotech Spin-Offs? Abstract pdf
Business Review Editor
Therapy Focus: Neuropathic Pain Abstract pdf
Business Review Editor

Licensing

Serono Licenses Aurora Kinase Inhibitors from Rigel Abstract pdf
Business Review Editor
Pfizer Hopes for Second Time Lucky in Anti-inflammatory Drugs Collaboration Abstract pdf
Business Review Editor

General

Bayer Helps J&J Expand Cardiology Franchise Abstract
Business Review Editor

Company Profile

Galapagos NV Abstract pdf
Business Review Editor

Distribution & Marketing

SkyePharma Signs Development and Marketing Agreement with Maruho Abstract pdf
Business Review Editor

Business Commentaries

Communication, Trust and the Deal Abstract html
Fintan Walton

Deal Trackers

Indiplon Abstract pdf
Business Review Editor

Mergers & Acquisitions

Novartis to Acquire the Remaining Stake in Chiron Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.